Sponsors (54)
The bill directs federal funding, screening, research, and reporting to improve early detection, treatment, and equity for uterine fibroids, but does so at added federal and state cost and with risks of uneven rollout, administrative burden, and gaps in funding, oversight, or equitable implementation.
Women (especially those in high-risk, low-income, and racial-ethnic minority communities) will gain earlier detection, screening, patient navigation, and public-awareness outreach for uterine fibroids, increasing timely diagnosis and reducing symptoms and complications.
Hospitals, clinics, and clinicians will receive evidence-based detection strategies and publicly available HHS reports that help standardize care and guide clinical best practices for intrauterine conditions.
Targeted research funding and clinical trials can produce better pain management, therapies, and surgical practices for uterine fibroids, improving outcomes for patients who need treatment.
Federal taxpayers and the federal budget will face increased costs from grant programs, HHS administration, and research funding, potentially diverting funds from other programs or requiring new appropriations.
Access improvements are likely to be uneven across states and localities — some women (including in rural areas) may not benefit quickly due to variable implementation, limited local capacity, or slow grant uptake.
Providers, hospitals, and state health agencies will face administrative, training, and grant-management burdens and costs to adopt new protocols and apply for or run grant programs.
Based on analysis of 5 sections of legislative text.
Authorizes HHS to research uterine fibroid early-detection strategies, award state grants for screening/education/access, fund related research, and requires biennial public reports.
Requires the Department of Health and Human Services (HHS) to research and develop evidence-based strategies to improve early detection and intervention for uterine fibroids and related intrauterine conditions, and authorizes HHS to award grants to states to run screening, patient navigation, education, and access programs. The bill also authorizes research grants (including clinical trials) on disparities in pain control for fibroid surgery and on Asherman’s syndrome and other intrauterine conditions, and it requires public biennial reports to Congress and posting on HHS’s website about grant programs and research findings.
Introduced July 15, 2025 by Shontel M. Brown · Last progress July 15, 2025